Risk factors

Australian study to monitor outcomes with ACEi/ARBs in COVID-19

An Australian study is aiming assess the impact continuing versus discontinuing renin angiotensin system blockade on the risk of SARS-CoV-2 infection in patients with uncomplicated hypertension. Led by Professor Alta Schutte  from the George Institute of Global Health in NSW, the study is looking to  recruit over 5,500 participants to investigate the possible effect of the ...

Already a member?

Login to keep reading.

© 2021 the limbic